Mdb Capital Holdings, LLC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
MDB Capital Holdings, LLC reported a net loss for Q3 2025, with total assets and equity decreasing significantly, while actively addressing material weaknesses in internal controls and navigating strategic shifts in its technology development segment.
NASDAQ
MDB Capital Holdings, LLC reported a significantly increased net loss for the second quarter and first half of 2025, driven by unrealized investment losses and a new equity loss from its deconsolidated eXoZymes subsidiary, alongside identified material weaknesses in internal controls.
NASDAQ
MDB Capital Holdings' Q1 2025 results reveal a net loss driven by unrealized investment losses and the adoption of equity method accounting for eXoZymes after its IPO.
NASDAQ
10-Q: MDB Capital Holdings Reports Q3 2024 Results: Operating Losses Widen Amidst Increased Expenses
MDB Capital Holdings reported a net loss of $8.4 million for the third quarter of 2024, driven by increased operating costs and unrealized losses on investment securities.
NASDAQ
10-Q: MDB Capital Holdings Reports Q2 2024 Results: Revenue Declines Amidst Increased Operating Costs
MDB Capital Holdings reported a net loss for the second quarter of 2024, driven by decreased fee income and increased operating expenses, despite gains in investment securities.
NASDAQ
MDB Capital Holdings reported a net loss of $7.6 million for the first quarter of 2024, driven by unrealized losses on investment securities and increased operating costs.